Seferović PM, Vardas P, Jankowska EA, et al. The Heart Failure Association Atlas: heart failure epidemiology and management statistics 2019. Eur J Heart Fail. 2021;23(6):906–14.

Article  PubMed  Google Scholar 

Vaduganathan M, Docherty KF, Claggett BL, et al. SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomized controlled trials. Lancet. 2022;400(10354):757–67.

Article  CAS  PubMed  Google Scholar 

Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Eur J Heart Fail. 2008;10(10):933–89.

Article  PubMed  Google Scholar 

Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur J Heart Fail. 2016;18(8):891–975.

Article  PubMed  Google Scholar 

McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for diagnosing and treating acute and chronic heart failure. Eur Heart J. 2021;42(36):3599–726.

Article  CAS  PubMed  Google Scholar 

Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: a Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895–1032.

PubMed  Google Scholar 

Vaduganathan M, Docherty KF, Claggett BL, et al. SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials. Lancet. 2022;400(10354):757–67.

Article  CAS  PubMed  Google Scholar 

Gallo G, Tocci G, Fogacci F, Battistoni A, Rubattu S, Volpe M. Blockade of the neurohormonal systems in heart failure with preserved ejection fraction: a contemporary meta-analysis. Int J Cardiol. 2020;316:172–9.

Article  PubMed  Google Scholar 

Basile C, Paolillo S, Gargiulo P, et al. Sacubitril/valsartan reduces cardiac decompensation in heart failure with preserved ejection fraction: a meta-analysis. J Cardiovasc Med (Hagerstown). 2023;24(1):44–51.

Article  PubMed  Google Scholar 

Savarese G, Stolfo D, Sinagra G, Lund LH. Heart failure with mid-range or mildly reduced ejection fraction. Nat Rev Cardiol. 2022;19(2):100–16.

Article  PubMed  Google Scholar 

Stolfo D, Fabris E, Lund LH, Savarese G, Sinagra G. From mid-range to mildly reduced ejection fraction heart failure: a call to treat. Eur J Intern Med. 2022;103:29–35.

Article  PubMed  Google Scholar 

Reddy YNV, Carter RE, Obokata M, Redfield MM, Borlaug BA. A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction. Circulation. 2018;138(9):861–70.

Article  PubMed  PubMed Central  Google Scholar 

Pieske B, Tschöpe C, de Boer RA, et al. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2019;40(40):3297–317.

Article  PubMed  Google Scholar 

Amanai S, Harada T, Kagami K, et al. The H2FPEF and HFA-PEFF algorithms for predicting exercise intolerance and abnormal hemodynamics in heart failure with preserved ejection fraction. Sci Rep. 2022;12(1):13.

Article  PubMed  PubMed Central  Google Scholar 

Churchill TW, Li SX, Curreri L, et al. Evaluation of 2 existing diagnostic scores for heart failure with preserved ejection fraction against a comprehensively phenotyped cohort. Circulation. 2021;143(3):289–91.

Article  PubMed  PubMed Central  Google Scholar 

Thibodeau JT, Drazner MH. The role of the clinical examination in patients with heart failure. JACC Heart Fail. 2018;6(7):543–51.

Article  PubMed  Google Scholar 

Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson W. AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895–1032.

PubMed  Google Scholar 

Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC, Investigators. ADHERE Scientific Advisory Committee and Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol. 2006;47(1):76–84.

Article  PubMed  Google Scholar 

Solomon SD, Rizkala AR, Lefkowitz MP, Shi VC, Gong J, Anavekar N, Anker SD, Arango JL, Arenas JL, Atar D, Ben-Gal T, Boytsov SA, Chen CH, Chopra VK, Cleland J, Comin-Colet J, Duengen HD, Echeverría Correa LE, Filippatos G, Flammer AJ, Galinier M, Godoy A. Baseline characteristics of patients with heart failure and preserved ejection fraction in the PARAGON-HF trial. Circ Heart Fail. 2018;11(7): e004962.

Article  PubMed  Google Scholar 

Drazner MH, Prasad A, Ayers C, Markham DW, Hastings J, Bhella PS, Shibata S, Levine BD. The relationship of right- and left-sided filling pressures in patients with heart failure and a preserved ejection fraction. Circ Heart Fail. 2010;3(2):202–6.

Article  PubMed  PubMed Central  Google Scholar 

Jering K, Claggett B, Redfield MM, Shah SJ, Anand IS, Martinez F, Sabarwal SV, Seferović PM, Kerr Saraiva JF, Katova T, Lefkowitz MP, Pfeffer MA. Burden of heart failure signs and symptoms, prognosis, and response to therapy: the PARAGON-HF trial. JACC Heart Fail. 2021;9(5):386–97.

Article  PubMed  Google Scholar 

Pfeffer MA, Shah AM, Borlaug BA. Heart failure with preserved ejection fraction in perspective. Circ Res. 2019;124(11):1598–617.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pieske B, Tschöpe C, de Boer RA, Fraser AG, Anker SD, Donal E, Edelmann F, Fu M, Guazzi M, Lam CSP, Lancellotti P, Melenovsky V, Morris DA, Nagel E, Pieske-Kraigher E, Ponikowski P, Solomon SD, Vasan RS, Rutten FH, Voors AA, Ruschitzka F, Paulus WJ, Sefer P. How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2019;40(40):3297–317.

Article  PubMed  Google Scholar 

Smiseth OA, Morris DA, Cardim N, et al. Multimodality imaging in patients with heart failure and preserved ejection fraction: an expert consensus document of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2022;23(2):e34–61.

Article  PubMed  Google Scholar 

Perrone-Filardi P, Paolillo S, Agostoni P, et al. Renin-angiotensin-aldosterone system inhibition in patients affected by heart failure: efficacy, mechanistic effects and practical use of sacubitril/valsartan. Position Paper of the Italian Society of Cardiology. Eur J Intern Med. 2022;102:8–16.

Article  CAS  PubMed  Google Scholar 

Elmadi J, Satish Kumar L, Pugalenthi LS, Ahmad M, Reddy S, Barkhane Z. Cardiovascular magnetic resonance imaging: a prospective modality in the diagnosis and prognostication of heart failure. Cureus. 2022;14(4): e23840.

PubMed  PubMed Central  Google Scholar 

Quarta G, Gori M, Iorio A, et al. Cardiac magnetic resonance in heart failure with preserved ejection fraction: myocyte, interstitium, microvascular, and metabolic abnormalities. Eur J Heart Fail. 2020;22(7):1065–75.

Article  PubMed  Google Scholar 

Del Torto A, Guaricci AI, Pomarico F, et al. Advances in multimodality cardiovascular imaging in the diagnosis of heart failure with preserved ejection fraction. Front Cardiovasc Med. 2022;9: 758975.

Article  PubMed  PubMed Central  Google Scholar 

Gargiulo P, Acampa W, Asile G, et al. 123I-MIBG imaging in heart failure: impact of comorbidities on cardiac sympathetic innervation. Eur J Nucl Med Mol Imaging. 2023;50(3):813–24.

Article  PubMed  Google Scholar 

Seo M, Yamada T, Tamaki S, et al. Prognostic significance of cardiac 123I-MIBG SPECT imaging in heart failure patients with preserved ejection fraction. JACC Cardiovasc Imaging. 2022;15(4):655–68.

Article  PubMed  Google Scholar 

Volpe M, Gallo G, Rubattu S. Endocrine functions of the heart: from bench to bedside. Eur Heart J. 2023;44(8):643–55.

Article  CAS  PubMed  Google Scholar 

Goetze JP, Bruneau BG, Ramos HR, Ogawa T, de Bold MK, de Bold AJ. Cardiac natriuretic peptides. Nat Rev Cardiol. 2020;17(11):698–717.

Article  CAS  PubMed  Google Scholar 

Gallo G, Rubattu S, Autore C, Volpe M. Natriuretic peptides: it is time for guided therapeutic strategies based on their molecular mechanisms. Int J Mol Sci. 2023;24(6):5131.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grewal J, McKelvie RS, Persson H, et al. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction. Am J Cardiol. 2008;102(6):733–7.

Article  CAS  PubMed  Google Scholar 

Dal Canto E, Scheffer M, Kortekaas K, Driessen-Waaijer A, Paulus WJ, van Heerebeek L. Natriuretic peptide levels and stages of left ventricular dysfunction in heart failure with preserved ejection fraction. Biomedicines. 2023;11(3):867.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kasahara S, Sakata Y, Nochioka K, et al. Comparable prognostic impact of BNP levels among HFpEF, borderline HFpEF and HFrEF: a report from the CHART-2 Study. Heart Vessels. 2018;33(9):997–1007.

Article  PubMed